Company: Glenmark Pharmaceuticals Ltd.
Ownership: Glenmark Pharmaceuticals Group
Project Location: India
Project Status: Completed  Project Type/Scale: New Unit
Industry: Drugs & Pharmaceuticals
Investment/Estimated Cost: Rs. 21.00 Crores / USD 5.25 Million

Monday, January 1, 2001	Date of announcement
Saturday, March 31, 2001	Completed

More projects (By Glenmark Pharmaceuticals Ltd.):

•	Baddi Pharmaceutical Formulation	•	Bulk Drugs	•	Drug Formulations
•	Gsk Ankleshwar Unit Upgradation